Well I think the nice thing here is that this run feels completely justified based on the current fundamentals. BRN was definitely a fair bit of people looking into the future (and there was definitely good future potential there), EYE however is getting enormous sales growth and making significant progress right now as we speak. Of course there's also a bit of people looking ahead here as well (eg major 2RT deal, near term profitability etc) but I do like that this run has felt completely justified on the basis of the "hard numbers" as opposed to purely hopes held by investors. If anything, this run has been largely is insufficient considering the fundamentals, and there should certainly be a premium ascribed to the future potential
That stock is definitely a good example though as to how high stocks can rally in a short period of time. I think everyone remembers watching that one run in awe. Would be amazing, but IMO completely justified, if EYE were to have a similar rally
- Forums
- ASX - By Stock
- EYE
- Nova Eye Medical (EYE) Discussion
Nova Eye Medical (EYE) Discussion, page-1827
-
-
- There are more pages in this discussion • 1,361 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.64M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 15.5¢ | $14.31K | 92.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 148500 | 15.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 124195 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 148500 | 0.150 |
8 | 558724 | 0.145 |
11 | 450030 | 0.140 |
2 | 14500 | 0.135 |
6 | 75850 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 124195 | 4 |
0.165 | 119997 | 2 |
0.170 | 200000 | 3 |
0.175 | 100000 | 1 |
0.180 | 100000 | 1 |
Last trade - 12.02pm 13/11/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online